デフォルト表紙
市場調査レポート
商品コード
1593453

陽電子放射断層撮影(PET)の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年~2031年

Positron Emission Tomography Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 204 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
陽電子放射断層撮影(PET)の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 204 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

陽電子放射断層撮影(PET)の世界市場規模は、2022年に23億5,000万米ドルと評価され、2023年の25億2,000万米ドルから2031年には42億1,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは6.61%で成長する見通しです。

がんやアルツハイマー病のような生命を脅かす病態の有病率の上昇が、診断と継続的な患者ケアを支援する高度なイメージング技術に不可欠なPETスキャンの需要を大きく促進しています。これらのスキャンは、体内の生理学的・代謝的プロセスに関する重要な洞察を提供し、ヘルスケア専門家が慢性疾患を効果的に評価・管理することを可能にし、最終的には患者の転帰と治療の成功を向上させる。慢性疾患が増え続ける中、標的治療薬や個別化医療の必要性が高まっており、PET検査は患者固有のニーズに合わせた治療を行う上で非常に貴重なものとなっています。これらの画像技術は、分子イメージング技術の進歩や、スキャンの精度と効率を高める人工知能(AI)と機械学習の取り込みにより、疾患の進行と治療反応を正確に測定できるように進化してきました。このような技術進化は、病状のより良い特定とフォローアップを容易にするだけでなく、様々な医療専門分野にわたる研究と臨床診断の両方においてPETスキャンの役割を拡大します。その結果、PETスキャン市場は力強い成長を遂げており、これは現代のヘルスケアにおけるPETスキャンの不可欠な役割と、より個別化された医療アプローチへの推進力を反映しています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • バリューチェーン分析
  • サプライチェーン分析
  • 特許分析
  • 貿易分析
  • 技術分析
  • 規制情勢
  • ケーススタディ分析

陽電子放射断層撮影市場:製品別

  • 市場概要
  • スタンドアロンPETシステム
  • PET/CTシステム
    • 低スライススキャナ
    • 中スライススキャナ
    • 高スライススキャナ
  • PET/MRIシステム

陽電子放射断層撮影市場:用途別

  • 市場概要
  • 腫瘍学
  • 神経学
  • 心臓血管
  • その他の用途

陽電子放射断層撮影市場:エンドユーザー別

  • 市場概要
  • 病院と外科センター
  • 診断および画像診断クリニック
  • 外来診療センター
  • その他のエンドユーザー

陽電子放射断層撮影市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • General Electric
  • Koninklijke Philips N.V.
  • Siemens AG
  • Shanghai United Imaging Healthcare Co., Ltd
  • Canon Inc.
  • Shimadzu Corporation
  • Mediso Ltd.
  • MinFound Medical Systems Co., Ltd
  • Neusoft Corporation
  • Bruker
  • CMR Naviscan
  • Kindsway Biotech
  • Hermes Medical Solutions
  • Sofie Biosciences
  • Prescient Medical Imaging
  • Reflexion
  • Cubresa Inc.
  • Synchropet, Inc.
  • Novartis
  • Revvity Inc.
目次
Product Code: SQMIG35D2276

Global Positron Emission Tomography Market size was valued at USD 2.35 billion in 2022 and is poised to grow from USD 2.52 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 6.61% during the forecast period (2024-2031).

The rising prevalence of life-threatening conditions like cancer and Alzheimer's disease has significantly fueled the demand for PET scans, which are essential for advanced imaging technologies that aid in diagnosis and ongoing patient care. These scans provide crucial insights into the physiological and metabolic processes within the body, enabling healthcare professionals to effectively assess and manage chronic conditions, ultimately improving patient outcomes and treatment success. As chronic illnesses continue to rise, there is an increasing need for targeted therapeutics and personalized medicine, making PET scans invaluable for tailoring treatments to unique patient needs. These imaging techniques have evolved to measure disease progression and therapeutic responses accurately, thanks to advancements in molecular imaging technology and the incorporation of artificial intelligence (AI) and machine learning, which enhance the precision and efficiency of scans. This technological evolution not only facilitates better identification and follow-up of medical conditions but also expands the role of PET scans in both research and clinical diagnostics across various medical specialties. Consequently, the market for PET scans is experiencing robust growth, reflecting their integral role in contemporary healthcare and the drive towards more personalized medical approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Positron Emission Tomography Market Segmental Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Positron Emission Tomography Market

The escalating incidence of chronic diseases, including cancer, Alzheimer's disease, and cardiovascular disorders, serves as a pivotal market driver for the Global Positron Emission Tomography (PET) market. As these conditions necessitate sophisticated imaging techniques for effective diagnosis and ongoing management, PET scans have become vital tools in the healthcare arsenal. They provide critical insights into metabolic and physiological functions, which are essential for formulating tailored treatment plans. The burgeoning patient population suffering from chronic illnesses worldwide enhances the demand for PET technology, thereby propelling market growth. This trend underscores the need for advanced diagnostic modalities to effectively navigate the complexities of chronic disease management.

Restraints in the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market faces significant restraints primarily due to the prohibitive costs associated with PET scanners. High purchase prices, coupled with substantial operational and maintenance expenses, pose hurdles for smaller medical facilities and diagnostic laboratories with limited budgets. This financial barrier restricts access to advanced imaging technologies, particularly in resource-constrained environments. As a result, the high costs hinder broader adoption and utilization of PET scanning services, ultimately stifling market growth and limiting the expansion of innovative applications that could enhance diagnostic capabilities and improve patient outcomes in the healthcare sector.

Market Trends of the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market is experiencing significant growth driven by the integration of machine learning and artificial intelligence into scanning technologies. These advancements enhance image capture, reconstruction, and analysis, leading to improved diagnostic accuracy and expedited procedures. AI algorithms facilitate the detection of subtle anomalies and ensure precise tumor characterization, which translates into faster and more effective patient care. Furthermore, the utilization of machine learning to predict patient outcomes facilitates personalized treatment plans based on imaging data. As these technologies evolve, their incorporation into PET systems is poised to transform clinical and research practices, driving market expansion and accessibility.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Supply Chain Analysis
  • Patent Analysis
  • Trade Analysis
  • Technology Analysis
  • Regulatory Landscape
  • Case Study Analysis

Positron Emission Tomography Market, By Product

  • Market Overview
  • Standalone PET Systems
  • PET/CT Systems
    • Low-Slice Scanners
    • Medium-Slice Scanners
    • High-Slice Scanners
  • PET/MRI Systems

Positron Emission Tomography Market, By Application

  • Market Overview
  • Oncology Applications
  • Neurological Applications
  • Cardiovascular Applications
  • Other Applications

Positron Emission Tomography Market, By End User

  • Market Overview
  • Hospitals And Surgical Centers
  • Diagnostic And Imaging Clinics
  • Ambulatory Care Centers
  • Other End Users

Positron Emission Tomography Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • General Electric
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shanghai United Imaging Healthcare Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediso Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MinFound Medical Systems Co., Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neusoft Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CMR Naviscan
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kindsway Biotech
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hermes Medical Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sofie Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prescient Medical Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reflexion
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cubresa Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synchropet, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments